Alliance Pharma Grows In US With Amberen Menopause Supplement

UK-based Alliance Pharma has strengthened its US offering by acquiring Biogix and its Amberen menopause supplement.

businessman and businesswoman are shaking hands and exchanging folder after agreement was reached
• Source: Shutterstock

Alliance Pharma plc has acquired El Segundo, CA-based Biogix Inc for $110m to expand its footprint in the US and enhance its offering in the dietary supplements market.

The deal adds to UK-based Alliance’s portfolio Biogix’ flagship brand Amberen, a supplement marketed for the relief of menopause symptoms,...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from United States

More from North America